Showing posts with label biosimilars. Show all posts

AIPPI Congress Report 3: Biosimilars – similar but different?

  The general configuration AIPPI attendee's saw the AmeriKat in during this year's Congress While the AmeriKat was busy meeting wit...

Fujifilm's second Arrow declaration survives AbbVie's strike out application as Humira biosimilar battle rages on

The AmeriKat normally needs to swim around in coffee to wake up, but Mr Justice Arnold's decision had the same impact this morning... Th...